Fundamentals

Valuation

Metric	Q1	Q3	Δ in %
EV/EBITDA	-97.04	114.06	-3858.81
Graham Fair Price	38.95	11.55	8.31
PEG	96.00	-0.98	0.50
Price/Book	0.35	0.89	0.89
Price/Cash Flow	-78.71	1.97	-9.24
Prices/Earnings	-20.54	13.22	16.64
Price/Sales	31.49	18.42	14.01
Price/FCF	-78.71	1.97	-9.24
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q1	Q3	Δ in %
Gross Profit Margin	6.18	0.66	0.62
Operating Margin	16.46	0.29	0.25
ROA	53.94	< 0.005	< 0.005
ROE	0.01	0.02	26.29
ROIC	< 0.005	< 0.005	7.67
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q1	Q3	Δ in %
Debt QOQ	0.09	0.22	-59.50
Dividends QOQ	-0.37	1.68	355.20
EBIT QOQ	0.71	-0.37	-47.80
EPS QOQ	0.33	-0.14	-59.46
FCF QOQ	-1.31	2.52	92.94
Revenue QOQ	-0.15	-0.27	-83.49
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q1	Q3	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	< 0.005	-100.00
Days Sales Outstanding (DSO)	1205.76	145.16	-87.96
Inventory Turnover	0.00	-2425477276.51	-100.00
Debt/Capitalization	0.79	0.73	-7.07
Quick Ratio	12.92	0.10	-99.21
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q1	Q3	Δ in %
Book Value	15.18	19.47	28.24
Cash	3.74	3.44	-7.88
Capex	-0.03	0.02	-8.22
Free Cash Flow	-1.46	8.49	482.76
Revenue	0.96	0.91	-5.64
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q1	Q3	Δ in %
Current Ratio	2.91	0.10	-96.48
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-3083.55	50.02	-98.38
Naive Interpretation	Member

06 - Financial Health · Bad

Rating